Tags - Xpovio

FDA approves Xpovio combo for treatment of refractory multiple myeloma

TEHRAN, Jul 11 - Xpovio (selinexor) tablets have been approved for use in combination with dexamethasone to treat adults with relapsed refractory multiple myeloma, the U.S. Food and Drug Administration announced last week.

News ID: 41854 Publish Date : 2019/07/11

Young journalists club

FDA approves Xpovio combo for treatment of refractory multiple myeloma

China’s EXIM inks $1.5bn deal for high-speed rail in Iran (1 Comment)